Akeso, Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies in Australia. AK138D1, a self-developed and ...
Akeso, Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment ...
Ivonescimab, the new drug, was found in a trial conducted in China to have bested Keytruda, the blockbuster medication ...
Genethon, a pioneering gene therapy research organization created by the AFM-Telethon, marks Rare Disease Day February 28, 2025, by highlighting recent technological breakthroughs signaling a next ...
New research from Appian , in partnership with Coforge (NSE: COFORGE), reveals that, on average, process inefficiency costs ...
XIAOMI-W (01810.HK), one of this year’s standout performers, opened 0.53% higher this morning (27th) and saw gains widen, ...
In a Chinese trial, trastuzumab rezetecan induced a 73% response rate in previously treated HER2-mutant non-small cell lung cancer (NSCLC). The safety profile of the novel antibody-drug conjugate was ...
Heralding the beginning of a new era, Kempinski Hotels have signed a landmark agreement to manage the Nymphenburg Palace ...
A young South African lady shared her reasons of quitting her job at Capitec Bank in a now-viral TikTok video. More people came forward with similar experiences.